Daniel M. Hancock - 22 Jun 2021 Form 4 Insider Report for Cryoport, Inc. (CYRX)

Role
Director
Signature
/s/ Daniel M. Hancock
Issuer symbol
CYRX
Transactions as of
22 Jun 2021
Net transactions value
-$719,850
Form type
4
Filing time
23 Jun 2021, 19:01:46 UTC
Previous filing
09 Jun 2021
Next filing
30 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYRX Common Stock Options Exercise $125,030 +12,850 +278% $9.73 17,477 22 Jun 2021 Direct F1
transaction CYRX Common Stock Sale $478,764 -7,306 -42% $65.53 10,171 22 Jun 2021 Direct F1, F2
transaction CYRX Common Stock Sale $366,116 -5,544 -55% $66.04 4,627 22 Jun 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYRX Option to purchase common stock Options Exercise $0 -12,850 -100% $0.000000* 0 22 Jun 2021 Common Stock 12,850 $9.73 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2021.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.90 to $65.86, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.995 to $66.11, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 2,850 of the options vest on January 17, 2019 and 1/4 of the remaining 10,000 options vest on the 17th of each month for four months beginning on 2/17/2019.